BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 28293802)

  • 1. History of hypertension, heart disease, and diabetes and ovarian cancer patient survival: evidence from the ovarian cancer association consortium.
    Minlikeeva AN; Freudenheim JL; Cannioto RA; Szender JB; Eng KH; Modugno F; Ness RB; LaMonte MJ; Friel G; Segal BH; Odunsi K; Mayor P; Zsiros E; Schmalfeldt B; Klapdor R; Dӧrk T; Hillemanns P; Kelemen LE; Kӧbel M; Steed H; de Fazio A; ; Jordan SJ; Nagle CM; Risch HA; Rossing MA; Doherty JA; Goodman MT; Edwards R; Matsuo K; Mizuno M; Karlan BY; Kjær SK; Høgdall E; Jensen A; Schildkraut JM; Terry KL; Cramer DW; Bandera EV; Paddock LE; Kiemeney LA; Massuger LF; Kupryjanczyk J; Berchuck A; Chang-Claude J; Diergaarde B; Webb PM; Moysich KB;
    Cancer Causes Control; 2017 May; 28(5):469-486. PubMed ID: 28293802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive medication use and ovarian cancer survival.
    Huang T; Townsend MK; Dood RL; Sood AK; Tworoger SS
    Gynecol Oncol; 2021 Nov; 163(2):342-347. PubMed ID: 34556331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertension, use of antihypertensive medications, and risk of epithelial ovarian cancer.
    Huang T; Poole EM; Eliassen AH; Okereke OI; Kubzansky LD; Sood AK; Forman JP; Tworoger SS
    Int J Cancer; 2016 Jul; 139(2):291-9. PubMed ID: 26934358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-diagnosis use of antihypertensive medications and the risk of death from ovarian cancer.
    Harding BN; Delaney JA; Urban RR; Weiss NS
    Gynecol Oncol; 2019 Aug; 154(2):426-431. PubMed ID: 31178150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. History of Comorbidities and Survival of Ovarian Cancer Patients, Results from the Ovarian Cancer Association Consortium.
    Minlikeeva AN; Freudenheim JL; Eng KH; Cannioto RA; Friel G; Szender JB; Segal B; Odunsi K; Mayor P; Diergaarde B; Zsiros E; Kelemen LE; Köbel M; Steed H; deFazio A; Jordan SJ; Fasching PA; Beckmann MW; Risch HA; Rossing MA; Doherty JA; Chang-Claude J; Goodman MT; Dörk T; Edwards R; Modugno F; Ness RB; Matsuo K; Mizuno M; Karlan BY; Goode EL; Kjær SK; Høgdall E; Schildkraut JM; Terry KL; Cramer DW; Bandera EV; Paddock LE; Kiemeney LA; Massuger LFAG; Sutphen R; Anton-Culver H; Ziogas A; Menon U; Gayther SA; Ramus SJ; Gentry-Maharaj A; Pearce CL; Wu AH; Kupryjanczyk J; Jensen A; Webb PM; Moysich KB; ;
    Cancer Epidemiol Biomarkers Prev; 2017 Sep; 26(9):1470-1473. PubMed ID: 28864456
    [No Abstract]   [Full Text] [Related]  

  • 6. The impact of perioperative β blocker use on patient outcomes after primary cytoreductive surgery in high-grade epithelial ovarian carcinoma.
    Al-Niaimi A; Dickson EL; Albertin C; Karnowski J; Niemi C; Spencer R; Shahzad MM; Uppal S; Saha S; Rice L; Nally AM
    Gynecol Oncol; 2016 Dec; 143(3):521-525. PubMed ID: 27693123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Joint exposure to smoking, excessive weight, and physical inactivity and survival of ovarian cancer patients, evidence from the Ovarian Cancer Association Consortium.
    Minlikeeva AN; Cannioto R; Jensen A; Kjaer SK; Jordan SJ; Diergaarde B; Szender JB; Odunsi K; Almohanna H; Mayor P; Starbuck K; Zsiros E; Bandera EV; Cramer DW; Doherty JA; DeFazio A; ; Edwards R; Goode EL; Goodman MT; Høgdall E; Matsuo K; Mizuno M; Nagle CM; Ness RB; Paddock LE; Pearce CL; Risch HA; Rossing MA; Terry KL; Wu AH; Modugno F; Webb PM; Moysich KB;
    Cancer Causes Control; 2019 May; 30(5):537-547. PubMed ID: 30905014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of beta blockers on survival outcomes in ovarian cancer: a nationwide population-based cohort study.
    Baek MH; Kim DY; Kim SO; Kim YJ; Park YH
    J Gynecol Oncol; 2018 Nov; 29(6):e82. PubMed ID: 30207092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-blocker use and mortality following ovarian cancer diagnosis: a population-based study.
    Couttenier A; Lacroix O; Silversmit G; Vaes E; De Schutter H; Robert A
    Cancer Epidemiol; 2019 Oct; 62():101579. PubMed ID: 31450179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis of ovarian cancer in women with type 2 diabetes using metformin and other forms of antidiabetic medication or statins: a retrospective cohort study.
    Urpilainen E; Marttila M; Hautakoski A; Arffman M; Sund R; Ilanne-Parikka P; Arima R; Kangaskokko J; Puistola U; Hinkula M; Läärä E
    BMC Cancer; 2018 Jul; 18(1):767. PubMed ID: 30055585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of diabetes mellitus on epithelial ovarian cancer survival.
    Akhavan S; Ghahghaei-Nezamabadi A; Modaresgilani M; Mousavi AS; Sepidarkish M; Tehranian A; Rezayof E
    BMC Cancer; 2018 Dec; 18(1):1246. PubMed ID: 30541490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiologic factors that predict long-term survival following a diagnosis of epithelial ovarian cancer.
    Kim SJ; Rosen B; Fan I; Ivanova A; McLaughlin JR; Risch H; Narod SA; Kotsopoulos J
    Br J Cancer; 2017 Mar; 116(7):964-971. PubMed ID: 28208158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of metabolic comorbidities and commonly used drugs on the prognosis of patients with ovarian cancer.
    Bar D; Lavie O; Stein N; Feferkorn I; Shai A
    Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():227-231. PubMed ID: 27890326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. History of thyroid disease and survival of ovarian cancer patients: results from the Ovarian Cancer Association Consortium, a brief report.
    Minlikeeva AN; Freudenheim JL; Cannioto RA; Eng KH; Szender JB; Mayor P; Etter JL; Cramer DW; Diergaarde B; Doherty JA; Dörk T; Edwards R; deFazio A; Friel G; Goodman MT; Hillemanns P; Høgdall E; Jensen A; Jordan SJ; Karlan BY; Kjær SK; Klapdor R; Matsuo K; Mizuno M; Nagle CM; Odunsi K; Paddock L; Rossing MA; Schildkraut JM; Schmalfeldt B; Segal BH; Starbuck K; Terry KL; Webb PM; Zsiros E; Ness RB; Modugno F; Bandera EV; Chang-Claude J; Moysich KB
    Br J Cancer; 2017 Sep; 117(7):1063-1069. PubMed ID: 28817835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative safety of diabetes medications and risk of incident invasive breast cancer: a population-based cohort study.
    Calip GS; Yu O; Elmore JG; Boudreau DM
    Cancer Causes Control; 2016 May; 27(5):709-20. PubMed ID: 27053250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival in Advanced Epithelial Ovarian Cancer Associated with Cardiovascular Comorbidities and Type 2 Diabetes Mellitus.
    Slavchev S; Kornovski Y; Yordanov A; Ivanova Y; Kostov S; Slavcheva S
    Curr Oncol; 2021 Sep; 28(5):3668-3682. PubMed ID: 34590605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of ß-blockers and mortality following ovarian cancer diagnosis: a population-based cohort study.
    Johannesdottir SA; Schmidt M; Phillips G; Glaser R; Yang EV; Blumenfeld M; Lemeshow S
    BMC Cancer; 2013 Feb; 13():85. PubMed ID: 23433478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smoking may modify the association between neoadjuvant chemotherapy and survival from ovarian cancer.
    Kelemen LE; Warren GW; Koziak JM; Köbel M; Steed H
    Gynecol Oncol; 2016 Jan; 140(1):124-30. PubMed ID: 26549109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of long-term antihypertensive and antidiabetic medications on the prognosis of post-surgical colorectal cancer: the Fujian prospective investigation of cancer (FIESTA) study.
    Peng F; Hu D; Lin X; Liang B; Chen Y; Zhang H; Xia Y; Lin J; Zheng X; Niu W
    Aging (Albany NY); 2018 May; 10(5):1166-1181. PubMed ID: 29846174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium.
    Nagle CM; Dixon SC; Jensen A; Kjaer SK; Modugno F; deFazio A; Fereday S; Hung J; Johnatty SE; ; Fasching PA; Beckmann MW; Lambrechts D; Vergote I; Van Nieuwenhuysen E; Lambrechts S; Risch HA; Rossing MA; Doherty JA; Wicklund KG; Chang-Claude J; Goodman MT; Ness RB; Moysich K; Heitz F; du Bois A; Harter P; Schwaab I; Matsuo K; Hosono S; Goode EL; Vierkant RA; Larson MC; Fridley BL; Høgdall C; Schildkraut JM; Weber RP; Cramer DW; Terry KL; Bandera EV; Paddock L; Rodriguez-Rodriguez L; Wentzensen N; Yang HP; Brinton LA; Lissowska J; Høgdall E; Lundvall L; Whittemore A; McGuire V; Sieh W; Rothstein J; Sutphen R; Anton-Culver H; Ziogas A; Pearce CL; Wu AH; Webb PM;
    Br J Cancer; 2015 Sep; 113(5):817-26. PubMed ID: 26151456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.